The approval of a new breast cancer treatment has given hope to thousands of women with an incurable form of the disease.

A new study reveals that the protein alpha-synuclein, known for its role in Parkinson’s disease, also contributes to the ...

A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run ...

Harvard no longer has a primate research center. But in 2009, Harvard’s Wyss Institute for Biologically Inspired Engineering ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) has been recommended by the National Institute for Health and Care Excellence (NICE) as part of a combination treatment for advanced breast ...

A grandma who has fought breast cancer for more than a decade may be forced to move to Scotland to access a lifesaving drug.

Beverley Angell, 68, is having to consider moving 467 miles from London to Scotland as the drug she needs - Enhurtu for HER2-low - is not available on the NHS in England. Privately it would cost ...

On the one hand, it memorializes an origin of Bachardy’s intense commitment to portraiture as an artistic genre. The Los ...

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Harvard University is such a perfect foil for Trumpism that it’s a wonder it avoided the MAGA maelstrom for so long.

Mia Love gathered Monday in Salt Lake City to honor the life and legacy of the first Black Republican woman elected to ...